An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia.
Marjanne A PienaNatalie HouwingCarla W KraanXiaofeng WangHeidi C WatersRuth A DuffySuresh MallikaarjunCraig BennisonPublished in: PharmacoEconomics (2021)
The analysis highlighted the robustness of the novel framework based on pharmacokinetic and pharmacodynamic evidence and demonstrated an application in a postmarketing setting.
Keyphrases